Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations

IH Bartelink, CMA Rademaker, AFAM Schobben… - Clinical …, 2006 - Springer
The approach to paediatric drug dosing needs to be based on the physiological
characteristics of the child and the pharmacokinetic parameters of the drug. This review …

The physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders

BP Chumpitazi, GL Kearns… - Alimentary pharmacology …, 2018 - Wiley Online Library
Background Peppermint oil has been used for centuries as a treatment for gastrointestinal
ailments. It has been shown to have several effects on gastrointestinal physiology relevant to …

Aflatoxin exposure in utero causes growth faltering in Gambian infants

PC Turner, AC Collinson, YB Cheung… - International journal …, 2007 - academic.oup.com
Abstract Background Growth faltering in West African children has previously been
associated with dietary exposure to aflatoxins, particularly upon weaning. However, in …

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

M Ingelman-Sundberg - Naunyn-Schmiedeberg's archives of …, 2004 - Springer
The cytochrome P450s are responsible for about 75% of phase I dependent drug
metabolism and for the metabolism of a huge amount of dietary constituents and …

[HTML][HTML] Paediatric specific dosage forms: Patient and formulation considerations

D Khan, D Kirby, S Bryson, M Shah… - International journal of …, 2022 - Elsevier
The total number of paediatric formulations available only account for a small proportion of
the full therapeutic plethora required to effectively treat paediatrics and, therefore, the …

Clinically and pharmacologically relevant interactions of antidiabetic drugs

M May, C Schindler - Therapeutic advances in endocrinology …, 2016 - journals.sagepub.com
Patients with type 2 diabetes mellitus often require multifactorial pharmacological treatment
due to different comorbidities. An increasing number of concomitantly taken medications …

CYP3A4*22: Promising Newly Identified CYP3A4 Variant Allele for Personalizing Pharmacotherapy

L Elens, T Van Gelder, DA Hesselink… - …, 2013 - Taylor & Francis
Many studies have attempted to explain the interindividual variability observed in drug
metabolism by assessing the impact of SNPs in genes implicated in drug absorption …

Developmental expression of the major human hepatic CYP3A enzymes

JC Stevens, RN Hines, C Gu, SB Koukouritaki… - … of Pharmacology and …, 2003 - ASPET
The human cytochrome P4503A forms show expression patterns subject to developmental
influence. CYP3A7 and CYP3A4 are generally classified as the major fetal and adult liver …

Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos

D Dai, J Tang, R Rose, E Hodgson, RJ Bienstock… - … of Pharmacology and …, 2001 - ASPET
CYP3A4 is the most abundant isoform of cytochrome P450 (CYP) in adult human liver. It
metabolizes numerous clinically, physiologically, and toxicologically important compounds …

Tissue distribution of MRNA expression of human cytochrome P450 isoforms assessedby high-sensitivity real-time reverse transcription PCR

M Nishimura, H Yaguti, H Yoshitsugu, S Naito… - Yakugaku …, 2003 - jstage.jst.go.jp
Pairs of forward and reverse primers and TaqMan probes specific to each human
cytochrome P450 isoform were prepared. Analysis of the mRNA level of each CYP isoform …